Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1979-08-13
1982-02-16
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
260112R, 424180, 536114, A61K 3702, A61K 3173, C07H 3700
Patent
active
043159184
ABSTRACT:
The gellation of polysaccharide gums such as guar or locust bean gum is inhibited by gelatin hydrolysates, at alkaline pH. Formulations of gum, gelatin hydrolysate and alkaliniser are reconstituted by shaking with water, and are easily inbibed. The inhibition is reversed by pH change in the stomach allowing gellation to occur. The formulation is useful in treatment of hypercholesteraemia, gastric disorders and as an adjunct to insulin therapy.
REFERENCES:
patent: 3313800 (1967-04-01), Jackson, Jr. et al.
patent: 3330706 (1967-07-01), Griffith
patent: 3360511 (1967-12-01), Farkas
patent: 3362951 (1968-01-01), Farkas et al.
patent: 3396034 (1968-08-01), Blondheim et al.
patent: 3415927 (1968-10-01), Butensky et al.
patent: 3712883 (1973-01-01), Nordgren
patent: 3989683 (1976-11-01), Staba
patent: 4098859 (1978-07-01), Cummisford et al.
patent: 4175124 (1979-11-01), Hyldon et al.
Gayst Stephen
Maguire Michael J.
Brown Donald
Brown Johnnie R.
LandOfFree
Pharmaceutical formulation of guar gum does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical formulation of guar gum, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulation of guar gum will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-942639